Call for Abstract

23rd Global Annual Oncologists Meeting, will be organized around the theme “Battle Together For A Cancer Free World”

Oncologists 2019 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Oncologists 2019

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Oncology is a branch of medication that arrangements with the anticipation, analysis, and treatment of growth. A therapeutic expert who hones oncology is an oncologist.
The three parts which have enhanced survival in malignancy are:
Avoidance – by decrease of hazard factors like tobacco and liquor utilization
Early conclusion – screening of regular cancersand thorough analysis and arranging
Treatment – multi methodology administration by talk in tumor board and treatment in an exhaustive disease focus.


  • Track 1-1Screening
  • Track 1-2Blood cancer
  • Track 1-3Lymphoma
  • Track 1-4Solid tumors

Cancer immunology is a branch of immunology that studies interactions between the immune system and cancer cells (also called tumours or malignancies). It is a field of research that aims to discover cancer immunotherapies to treat and retard progression of the disease. Cancer immunotherapy also known as Immuno-oncology is the use of the immune system to treat cancer. Immunotherapies can be categorized as active, passive or hybrid (active and passive). The immune response, including the recognition of cancer-specific antigens, forms the basis of targeted therapy (such as vaccines and antibody therapies) and tumour marker-based diagnostic tests.


  • Track 2-1Surgery
  • Track 2-2Radiation
  • Track 2-3Targeted therapy
  • Track 2-4Immuno-oncology

Many factors influence the development of cancer. Over the last 25 years, science has shown that diet, physical activity, and body weight—especially being overweight or obese—are major risk factors for developing certain types of cancer. Around a third of the most common cancers could be prevented through lifestyle changes. The main behavioural and environmental risk factors for cancer mortality in the world are related to diet and physical inactivity, use of addictive substances, sexual and reproductive health and exposure to air pollution and use of contaminated needles. The body’s ability to resist cancer may be helped by following a healthy diet, staying physically active, and avoiding excess body fat.  Cancer and cancer treatments can also affect your body's ability to tolerate certain foods and use nutrients.


  • Track 3-1Body weight, physical activity and cancer
  • Track 3-2Mechanisms of nutritional carcinogenesis and anti-carcinogenesis
  • Track 3-3Trials on the dietary prevention of cancer
  • Track 3-4Gene-nutrient interactions
  • Track 3-5Cancer prevention: global implications of new European evidence

Oncology Nursing is a field involving practice encompasses the roles of direct caregiver, educator, consultant, administrator, and researcher. Oncology and cancer nursing extends to all care delivery settings where clients experiencing or at risk for developing cancer receive health care, education, and counselling for cancer prevention, screening and detection. It also involves appropriate screenings and other preventative practices, symptom management, care to retain as much normal functioning as possible, and supportive measures upon end of life.


  • Track 4-1Oncology APN
  • Track 4-2Oncology RN
  • Track 4-3Primary palliative care
  • Track 4-4Specialty palliative care

Unlike diagnostic efforts prompted by symptoms and medical signs, cancer screening involves efforts to detect cancer after it has formed, but before any noticeable symptoms appear. This may involve physical examination, blood or urine tests or medical imaging.  

Cancer screening is not available for many types of cancers. Even when tests are available, they may not be recommended for everyone. Universal screening or mass screening involves screening everyone. Selective screening identifies people who are at higher risk, such as people with a family history. Several factors are considered to determine whether the benefits of screening outweigh the risks and the costs of screening. These factors include:

  •  Possible harms from the screening test: for example, X-ray images involve xposure to potentially harmful ionizing radiation
  •  The likelihood of the test correctly identifying cancer
  • The likelihood that cancer is present: Screening is not normally useful for rare cancers.


  • Track 5-1Screening mammography
  • Track 5-2Prostate Cancer Screening
  • Track 5-3Pancreatic Cancer Screening
  • Track 5-4Oral Cancer Screening
  • Track 5-5Lung Cancer Screening

Investigations of growth attack/metastasis and medication opposition have in the past for the most part continued along the different pathways of research. As of late, nonetheless, intrigue has been centered around the conceivable connection between sedate obstruction and growth intrusion and metastasis

  • Track 6-1Metastasis
  • Track 6-2MDR and Calcium Channel Blockers
  • Track 6-3Apoptosis
  • Track 6-4Animal models

Targeted therapy is a special type of chemotherapy that exploits differences between normal cells and tumor cells. It's occasionally utilized alone, however frequently other disease medicines are utilized with targeted therapy.

As the name proposes, targeted therapies interfere with particular proteins engaged with tumorigenesis. Instead of utilizing expansive base growth medications, concentrating on particular atomic changes which are one of a kind to a specific disease, directed tumor treatments might be all the more remedially gainful for some malignancies, including lung, colorectal, breast, lymphoma and leukemia.

Targeted drugs can work to:

  • Block or turn off chemical signals that tell the cancer cell to grow and divide
  • Change proteins within the cancer cells so the cells die
  • Stop making new blood vessels to feed the cancer cells
  • Trigger your immune system to kill the cancer cells
  • Carry toxins to the cancer cells to kill them, but not normal cells


An oncology nurse is a nursing professional who specializes in caring for people with cancer. Oncology nurses often serve as your first line of communication, and help coordinate the many aspects of your care throughout cancer treatment. Nursing Management is an important chapter of the nursing education. The nursing professionals in radiation oncology field will be highly demandable. Oncology nursing professionals mostly gives the palliative care for patients and comforts them. Cancer Congress 2018 will create a new revolution in cancer science and cancer nursing field.


  • Track 8-1Nursing education
  • Track 8-2Nursing Management
  • Track 8-3Clinical Nursing
  • Track 8-4Critical Care
  • Track 8-5Continuing Nursing Education

A multidisciplinary approach to overhaul has been applied in a variation of settings in clinical oncology, particularly among patients with stomach and colorectal cancer. Multidisciplinary care incorporates various disciplines that existing resources to enhance treatment plans and develops patients’ worth of life. Although the contribution of clinical pharmacists as part of the multidisciplinary team in the oncology department. Cancer Drugs were applied in order to treat the cancer and reducing symptoms of the cancer, and side-effects, such as nausea. Doctors would treat the cancer patients with two or more drugs that were used in chemotherapy and rarely with other medicines, such as steroids. Anti-cancer drugs eliminate cancer cells by preventing growth or obstructing multiplication at certain point in their life cycles. Vaccines were medicines that develops the immune system's natural ability to safeguard the body from “foreign invaders,” that mainly forms an infectious agents that may cause hereditary disease. HPV vaccine and Hepatitis B vaccine were cancer prevention vaccines supported by the U.S. Food and Drug Administration (FDA). Cancer treatment vaccines were also called therapeutic vaccines that increase the capability of immune system to acknowledge and abolish the antigens.


  • Track 9-1Theoretical Medicines
  • Track 9-2Anti-Metabolite Drugs
  • Track 9-3Alkylating Agents
  • Track 9-4Microtubule Inhibitor
  • Track 9-5Steroid Hormones
  • Track 9-6Miscellaneous Agents
  • Track 9-7Natural Agents
  • Track 9-8HMT Inhibitors
  • Track 9-9Biological Respond Modifier

A biopsy is the evacuation of a little measure of tissue. It is an imperative way specialists analyze a wide range of sorts of growth. After a biopsy, your social insurance group finishes a few stages previously the pathologist makes a conclusion. A pathologist is a specialist who works in deciphering research facility tests and assessing cells, tissues, and organs to analyze illness.


  • Track 10-1Hyperplasia
  • Track 10-2Dysplasia
  • Track 10-3Neoplasia
  • Track 10-4Sarcoma

Oncogenomics is a sub-field of genomics that describes disease related qualities. It centers around genomic, epigenomic and transcript modifications in cancer.Cancer is a hereditary malady caused by collection of DNA changes and epigenetic adjustments prompting over the top cell multiplication and neoplasm arrangement.


  • Track 11-1Genome sequencing
  • Track 11-2Transcriptomes
  • Track 11-3Whole genome sequencing
  • Track 11-4Databases for cancer research

Investigations of growth attack/metastasis and medication opposition have in the past for the most part continued along the different pathways of research. As of late, nonetheless, intrigue has been centered around the conceivable connection between sedate obstruction and growth intrusion and metastasis

Clinical Trials are inquire about investigations that include individuals. Clinical Trials are the completing advance in a long procedure that starts with explore in a lab. Before any new treatment is utilized with individuals in Clinical Trials, scientists work for a long time to comprehend its impacts on Cancer cells in the lab and in creatures. They likewise attempt to make sense of the symptoms it might cause. Preliminaries are accessible for all phases of Cancer. It is a legend that they are just for individuals who have propelled Cancer that isn't reacting to treatment.


  • Track 13-1Advancements in Clinical Trials for Drug Development
  • Track 13-2Preclinical and Clinical research for cancer therapies
  • Track 13-3Cancer Clinical trials data management
  • Track 13-4Guidelines for Cancer Clinical trials
  • Track 13-5Drug Discovery & Development

The study of disease transmission of malignancy is the investigation of the variables influencing growth, as an approach to derive conceivable patterns and causes. The investigation of growth the study of disease transmission utilizes epidemiological strategies to discover the reason for malignancy and to recognize and create enhanced medications.


  • Track 14-1Single nucleotide polymorphism
  • Track 14-2Glioma
  • Track 14-3Glioma
  • Track 14-4Selenium

Pharmacology deals with action of drug in the body. Cancer Pharmacology deals with the drugs used in cancer treatment, their mechanism of action, their side effects and their mode of elimination. Combination of Drugs and their efficacy has been a major choice of research interest.


  • Track 15-1Cancer Drugs
  • Track 15-2Anti-cancer drugs mechanism of action
  • Track 15-3Cancer Drugs absorption and Distribution
  • Track 15-4Cancer Drugs Metabolism
  • Track 15-5Side Effects of Synthetic Drugs in Cancer Treatment